CS
VRTX icon

Comerica Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Comerica Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$539K Sell
1,549
-235
-13% -$82.2K 0.04% 268
2023
Q2 		$628K Buy
1,784
+14
+0.8% +$4.72K 0.04% 274
2023
Q1 		$558K Sell
1,770
-422
-19% -$127K 0.04% 285
2022
Q4 		$633K Sell
2,192
-89
-4% -$27.1K 0.05% 274
2022
Q3 		$660K Buy
2,281
+58
+3% +$16.7K 0.05% 254
2022
Q2 		$626K Sell
2,223
-758
-25% -$203K 0.05% 276
2022
Q1 		$778K Sell
2,981
-296
-9% -$70.2K 0.05% 272
2021
Q4 		$720K Buy
3,277
+300
+10% +$58.3K 0.05% 277
2021
Q3 		$540K Buy
2,977
+116
+4% +$22.6K 0.04% 304
2021
Q2 		$577K Buy
2,861
+798
+39% +$167K 0.04% 293
2021
Q1 		$443K Buy
2,063
+558
+37% +$123K 0.03% 334
2020
Q4 		$356K Buy
1,505
+369
+32% +$84.7K 0.03% 350
2020
Q3 		$309K Buy
1,136
+265
+30% +$73.1K 0.03% 345
2020
Q2 		$253K Sell
871
-3
-0.3% -$813 0.02% 366
2020
Q1 		$208K Buy
+874
New +$200K 0.02% 374
2017
Q1 		– Sell
-6,605
Closed -$487K – 441
2016
Q4 		$487K Buy
6,605
+181
+3% +$14.7K 0.12% 196
2016
Q3 		$560K Buy
+6,424
New +$607K 0.11% 206

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Securities's VRTX Position: Q3 2023 in Review

Comerica Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q3 2023, selling an estimated $82.2K and leaving 1,549 shares worth $539K. The position accounts for 0.04% of the portfolio, ranked #268.

Comerica Securities first reported a position in VRTX in Q3 2016 and has held it in 17 quarters since. The position peaked at $778K in Q1 2022. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Comerica Securities held 1,549 shares of Vertex Pharmaceuticals worth $539K as of Q3 2023.
  • Comerica Securities sold 235 Vertex Pharmaceuticals shares in Q3 2023, an estimated $82.2K.
  • Vertex Pharmaceuticals made up 0.04% of Comerica Securities's portfolio in Q3 2023, its #268 holding.
  • Comerica Securities first reported a position in Vertex Pharmaceuticals in Q3 2016 and has held it in 17 quarters since.
  • Comerica Securities's Vertex Pharmaceuticals position peaked at $778K in Q1 2022.
  • 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.